Basic Information
Basic information for HCG18-235-39aa-2
Peptide Name HCG18-235-39aa-2
Genome Position chr6:30290818-30290926,30296230-30296237[-]
Species Human
Peptide Sequence MNRTEANIKASQPKVLWCRQDSKRTDYLVEPSIVLLLQH
Peptide Length 39
Unique No (HCG18-234-39aa,HCG18-236-39aa-1,HCG18-237-39aa-2,HCG18-238-39aa-2,HCG18-239-39aa-2,HCG18-241-39aa-2,HCG18-247-39aa,HCG18-248-39aa-2,HCG18-250-39aa-1,HCG18-251-39aa-1,HCG18-252-39aa-1,HCG18-253-39aa,HCG18-254-39aa-2,HCG18-256-39aa-1,HCG18-257-39aa-1,HCG18-260-39aa-1,HCG18-261-39aa-1,HCG18-262-39aa,HCG18-263-39aa-1,HCG18-264-39aa,HCG18-265-39aa-1,HCG18-267-39aa)
Grand Average of Hydropathicity -0.5256
Relative Molecular Mass 5266.93
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000231074;HCG18
Transcript ID/Name ENST00000426882;HCG18-235
Transcript Length 5050
Coding Ability 0.4182
DNA Sequence Corresponding to Peptide ATGAACAGGACTGAAGCCAATATTAAAGCAAGTCAACCAAAGGTTCTCTGGTGTAGACAAGACAGCAAAAGGACAGACTACCTTGTGGAACCTAGCATTGTTCTCCTTCTGCAGCAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :